Fluidomat (522017)

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹644.75, Fluidomat is not the kind of bargain Graham would endorse, and Buffett would want more evidence before committing capital. The market cap is ₹327 Cr, but the earnings power has clearly slipped: sales fell 13.28% and profits collapsed 57.93%. The latest quarter’s ₹14 Cr sales and ₹2 Cr net profit suggest the trailing P/E of 17.5 overstates the current earning power; annualized, the latest quarter implies an earning yield of only about 2.4%. That is concerning when I am also paying 4.70 times book value for a business whose returns are falling. The historical ROE of 23.19% and ROCE of 42.24% are exceptional and point to a genuine high-return franchise in good times. That tells me there is quality underneath this business. But the Piotroski F-Score of 3/9 warns that financial health is deteriorating, and the profit decline is far steeper than the sales decline, suggesting margin compression. The 52-week range, from ₹550 to ₹1096.45, shows the market has already punished the stock, now sitting near the lower end. The dividend yield of 1.31% offers little support if earnings keep slipping, and I cannot claim the comfort of a debt-free balance sheet because the debt/equity figure is not provided. This is not a Stalwart; it looks like a Cyclical business facing a sharp downturn in demand. Buffett would say it is better to buy wonderful businesses at fair prices, but 17.5 times falling earnings and a 3/9 F-score mean the price is not clearly fair. I would wait for quarterly evidence that sales stabilize and margins begin recovering before stepping in.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer